Please note you are entering now content intended only for Healthcare Professionals.
Are you a HCP?
Minimally invasive solutions
to help you provide
Better patient outcomes
We strive to be the leading innovator in gastroenterology and hepatology, relentlessly focused on improving patient outcomes and setting new standards of care. Our technologies can expand your ability to deliver early detection and treatment of GI diseases and cancers. Our support will eliminate barriers and strengthen your business with high-quality, reliable resources that include Clinical Education and Product support.
We are immensely proud to have won the NHS AI award. It will allow us to work in partnership with King’s College Hospital (KCH) and the NHS to assess GI GeniusTM intelligent endoscopy module in real-world conditions, in busy GI departments across the country. Bowel cancer kills more people in the UK than almost any other cancer and this trial will further our mission to detect early and improve patient outcomes.
Darin Wilson, Business Unit Leader Western Europe, Medtronic
We are proud to announce, in partnership with the European Society of Gastrointestinal Endoscopy, the first Artificial Intelligence Research Award valued at €1.5 million, to help the detection of colorectal cancer.
The ESGE Medtronic Research Award supports Artificial Intelligence (AI) research in the field of colonoscopy.
The Detect, Resect, Protect (DRP) concept follows the patient pathways from detection with the artificial intelligence system GI Genius™, to resection with the ProdiGI™ ESD product portfolio and to bleeding prevention with Nexpowder™*, a new endoscopic, topical powder.
As a leader in the Gastrointestinal & Hepatology field, Medtronic offers a comprehensive GI training programme to help participants develop their expertise and achieve better patient outcomes.
The Medtronic GI learning offering is a well-established programme delivered by leading faculties from various European hospitals. Delegates will undergo a combination of teaching and learning methods, including online training, lectures, and peer-to-peer discussions.
The Emprint™ HP ablation zone app puts the ablation setting details you need in the palm of your hand. With comprehensive ex vivo and in vivo ablation zone reference values, you can create tailored ablation zones2 with confidence.
This educational application offers an interactive experience that provides useful information about procedural steps, handling, and usage of these devices — in a 3D simulated environment.† This app is suitable for iPad®, and is free to download and install.
† This app is for simulation purposes only and does not reflect actual use of the device in a clinical setting with actual equipment. It is also not to be used for training purposes but for demonstration only. While every reasonable precaution has been taken in the preparation of this guide, Medtronic assumes no responsibility for errors or omissions, nor for the uses made of the materials contained herein and the decisions based on such use. This document does not contain all of the information necessary for the proper care and treatment of patients. As such, no individual may rely on the information presented herein in forming a comprehensive treatment program or in treating any patient. No warranties are made, expressed or implied, with regard to the contents of this work or to its applicability to specific patients or circumstances. Medtronic shall not be liable for direct, indirect, special, incidental or consequential damages arising out of the use or inability to use the contents of this guide.
™* Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
1. Cotter J, Castro F, Magalhaes J, Moreira M, Rosa B. Validation of the Lewis score for the evaluation of small-bowel Crohn’s disease activity. Endoscopy. 2015 Apr;47(4):330-5.
2. Based on internal test report #RE00085432, An acute GLP study to evaluate the performance and safety of the Emprint SX ablation platform in a porcine model. 2017